FDA Basics Webinar: A Brief Overview of Risk Evaluation and Mitigation Strategies (REMS)
In 2007, a new law that gave FDA many new authorities and responsibilities to enhance drug safety was enacted. It's called the Food and Drug Administration Amendments Act- sometimes called "FDAAA"- and one of its provisions gave FDA the authority to require a Risk Evaluation and Mitigation Strategy-(REMS) from manufacturers to ensure that the benefits of a drug or biological product outweigh its risks.
A REMs may be required by the FDA as part of the approval of a new product, or for an approved product when new safety information arises. Essentially, a REMS is a safety strategy to manage a known or potential serious risk associated with a medicine and to enable patients to have continued access to such medicines by managing their safe use.
Since medicines are very different from each other, each REMS for each medicine is also different.
This presentation discussed REMS and how they are used to help ensure that the benefits of certain medicines continue to outweigh their risks.
A Brief Overview of Risk Evaluation and Mitigation Strategies (REMS)
Adobe Connect link
FDA Basics Webinar: A Brief Overview of REMS(PDF - 1.2MB)
Download Presentation Slides
- What is a biological product?
- Upcoming Webinar-Food Safety: Bad Weather Basics
- July: CBER's Direct Recall Classification Program
- Webinar on FDA’s Safety Monitoring of Approved Vaccines
- What part of FDA regulates tobacco products?
- FDA Basics – OCTGT Webinar on Tissue Safety
- FDA Webinar on Safety of the Blood Supply
- FDA Webinar on Protecting Your Child's Health Through Safe and Effective Vaccines
- What are stem cells? How are they regulated?
- FDA Basics Webinar: State Enforcement Program
- How does FDA plan to enforce the restrictions on promotion and advertising established by the Tobacco Control Act?
- Does FDA have the authority to regulate tobacco products?
- What are the priorities of the Center for Tobacco Products?
- What is the main goal in regulating tobacco products?
- What products are considered to be tobacco products as defined by the tobacco control act?
- What products are not considered to be tobacco products as defined by the tobacco control act?
- Is FDA going to ban tobacco?
- How does the regulation of tobacco products differ from FDA’s regulation of drugs or medical devices?
- What are some of the key regulatory timelines associated with the tobacco control act?
- What will FDA do to curb tobacco use among children and adolescents?
- What are the new Regulations Restricting the Sale and Distribution of Cigarettes and Smokeless Tobacco to Protect Children and Adolescents?
- What are FDA’s Regulations for Flavored Tobacco?
- What safety information is available for FDA-regulated medical products and foods?
- What Should I Do If I See Violations of FDA’s Tobacco Products Rules?
- How do I report a problem with an FDA-regulated product?
How helpful was this information?